These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rapamycin and rapalogs for tuberous sclerosis complex. Sasongko TH, Ismail NF, Zabidi-Hussin Z. Cochrane Database Syst Rev; 2016 Jul 13; 7(7):CD011272. PubMed ID: 27409709 [Abstract] [Full Text] [Related]
4. Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex. Cappellano AM, Senerchia AA, Adolfo F, Paiva PM, Pinho R, Covic A, Cavalheiro S, Saba N. Childs Nerv Syst; 2013 Dec 13; 29(12):2301-5. PubMed ID: 23743818 [Abstract] [Full Text] [Related]
5. Everolimus tablets for patients with subependymal giant cell astrocytoma. Turner SG, Peters KB, Vredenburgh JJ, Desjardins A, Friedman HS, Reardon DA. Expert Opin Pharmacother; 2011 Oct 13; 12(14):2265-9. PubMed ID: 21806479 [Abstract] [Full Text] [Related]
6. Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex. Yalon M, Ben-Sira L, Constantini S, Toren A. Childs Nerv Syst; 2011 Jan 13; 27(1):179-81. PubMed ID: 20703486 [Abstract] [Full Text] [Related]
13. EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex. Fogarasi A, De Waele L, Bartalini G, Jozwiak S, Laforgia N, Verhelst H, Petrak B, Pedespan JM, Witt O, Castellana R, Crippa S, Gislimberti G, Gyorsok Z. BMC Neurol; 2016 Aug 08; 16():126. PubMed ID: 27502586 [Abstract] [Full Text] [Related]
14. Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA). Ebrahimi-Fakhari D, Franz DN. Expert Opin Pharmacother; 2020 Aug 08; 21(11):1329-1336. PubMed ID: 32338549 [Abstract] [Full Text] [Related]
15. Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex. Perek-Polnik M, Jóźwiak S, Jurkiewicz E, Perek D, Kotulska K. Eur J Paediatr Neurol; 2012 Jan 08; 16(1):83-5. PubMed ID: 22000822 [Abstract] [Full Text] [Related]
16. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex. Kotulska K, Chmielewski D, Borkowska J, Jurkiewicz E, Kuczyński D, Kmieć T, Łojszczyk B, Dunin-Wąsowicz D, Jóźwiak S. Eur J Paediatr Neurol; 2013 Sep 08; 17(5):479-85. PubMed ID: 23567018 [Abstract] [Full Text] [Related]
17. Everolimus: in patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex. Curran MP. Paediatr Drugs; 2012 Feb 01; 14(1):51-60. PubMed ID: 22136276 [Abstract] [Full Text] [Related]
18. Acute Management of Symptomatic Subependymal Giant Cell Astrocytoma With Everolimus. Arroyo MS, Krueger DA, Broomall E, Stevenson CB, Franz DN. Pediatr Neurol; 2017 Jul 01; 72():81-85. PubMed ID: 28511812 [Abstract] [Full Text] [Related]
19. Everolimus and giant-cell astrocytomas in tuberous sclerosis. Jia J, Xiong L, Chen S. N Engl J Med; 2011 Feb 10; 364(6):577. PubMed ID: 21306252 [No Abstract] [Full Text] [Related]